sciencedaily.com/releases/2...
This article states that high normal levels of T4 in women (during early gestation) treated for hypothyroidism have negative effects on foetal brain development similar to low levels.
The article uses this finding to excuse not treating women with subclinical hypothyroidism. Despite not testing T3 levels in these groups. As usual not looking at the whole picture. Perhaps this would indicate that high T4 levels in the absence of adequate T3 is the real issue, signalling conversion issues.
This may in some way challenge Dr Tofts statements about some patients requiring above range T4 to feel well. Surely adding T3 would be the wisest move especially in young women?
Healthy women (with mid range T4) do not require high levels of thyroxine to achieve good T3 levels. Therefore I think T3/T4 combination therapy is important in order to achieve optimal levels in those with conversion issues. This would be preferential above excessive dosages of T4 beyond normal pregnancy ranges.
Again and again it seems balance is key, which requires more than one treatment option.